Philip's recent experience includes advising:
? the transfer of the controlling stake of HKICIM Group and the triggering of a Mandatory General Offer under the Takeovers and Mergers Code;
? a family fund invested in Terminus (an AI business company) as a private equity investor;
? CDB International Investment Limited sold a 29.99% stake in China New Town, a Hong Kong-listed real estate company (obtaining confirmation from the Securities and Futures Commission that it would not trigger a Mandatory General Offer under the Takeovers and Mergers Code);
? China Mobile's investment in a Hong Kong-listed software company, which may trigger Hong Kong's Takeovers Code obligations to provide advice and represent it in negotiations with the Hong Kong Securities and Futures Commission;
? Clarity Medical on its listing and global offering in Hong Kong;
? Genor Biopharma (holding company of Hillhouse Capital) on its listing and global offering in Hong Kong;
? Morgan Stanley Private Equity in the listing and global offering of its wholly-owned investee company Home Control on the Hong Kong Stock Exchange;
? Morgan Stanley Private Equity obtained an overseas M&A loan and acquired equity in a domestic company;
? ChemChina: Advising on the restructuring of Syngenta Group, ChemChina and Sinochem Corporation and the acquisition of a controlling stake in Hong Kong-listed Sinochem Hong Kong Holdings Limited;
? various transactions with Blackstone, Henderson Land, Wheelock Property and other prominent counterparties for aggregated consideration of over US$3 billion; regulators’ queries, compliance to applicable laws and rules, various financing and refinancing transactions, etc;
? HNA Foods: advising on its proposed acquisition of a Hong Kong-listed food company and making a general offer;
? HNA Investment: Advising on its proposed acquisition of a controlling stake in a Hong Kong-listed financial sector company through a voluntary partial tender offer;
? China Mobile's investment in a Hong Kong-listed H-share company;
? Hong Kong International Construction Investment (687.hk) invested in Hong Kong Airlines;
? the sponsors in the spin off and Hong Kong listing of BOCOM International Holdings Company Limited;
? VPower, a Hong Kong-based international power solutions company on its listing and global offering in Hong Kong;
? China Resources Pharmaceutical on its listing and global offering in Hong Kong;
? China Huarong's investment in MI Energy, an energy company, was restructured;
? a transaction in which an affiliate of China Travel Service International increased its capital in China National Tourism Administration;
? major transaction in which China General Nuclear Power Co., Ltd. acquired the assets of China General Nuclear Power Group for approximately RMB10 billion;
? well-known companies such as China National Offshore Oil Corporation, COFCO, Beijing Enterprises Holdings, KKR, CICC Capital, Sequoia Capital, and China Life Fund for analysis and transactions under Hong Kong law;
? BAML and UBS in the approximately US$1.2 billion global offering and Hong Kong listing of Everbright Securities;
? CICC, BAML and ABCI in the Hong Kong listing and global offering of CGN Power Co., Ltd. of approximately US$3 billion. CGN Power is the first and only nuclear power operator listed on the Hong Kong Stock Exchange;
? BOCI, CCBI and ABCI in the approximately US$1 billion global offering and Hong Kong listing of Bank of Tianjin;
? the sponsors in the approximately US$8 billion global offering and Hong Kong listing of China Postal Savings Bank;
? Morgan Stanley in the approximately US$200 million IPO and listing of PW Medtech Limited, a leading medical device company in China, on the Main Board of the Hong Kong Stock Exchange;
? Morgan Stanley, UBS, J.P. Morgan, BOCI, CITIC in the approximately US$1.36 billion IPO and listing of Huishang Bank Corporation Limited, the largest city commercial bank in Anhui, China, on the Main Board of the Hong Kong Stock Exchange;
? J.P. Morgan, Morgan Stanley and UBS, as underwriters, on the US$1.9 billion Hong Kong listing and Rule 144A global offering of Wynn Macau Limited, owner and operator of casinos and resorts;
? the underwriters in the Hong Kong listing and global offering plan of an online gaming company in PRC with VIE structure;
? J.P. Morgan on the listing of a mining subsidiary of Wuhan Iron and Steel (Group) Corporation;
? Goldman Sachs and Morgan Stanley, as underwriters, on the US$450 million red-chip listing and Rule 144A global offering of Yingde Gases Group Company, a leading industrial gas supplier in China;
? Kunlun Energy in respect of its very substantial acquisition of Petrochina Kunlun Gas for over US$2.3 billion;
? on the top-up placing of Hong Kong-listed companies such as Sino Biopharmaceutical Limited, China Agri-Industries Holdings Limited, and Kunlun Energy, Real Gold Mining Limited;
? New World Development on its potential large scale acquisition of a Grade-A property in Hong Kong;
? Singamas on its application for whitewash exemption under the Takeovers Code from the Securities and Futures Commission of Hong Kong in connection with the rights issue;
? NWS Holdings Limited in its pre-IPO investment in an infrastructure technology solutions company;
? GIC Private Ltd in respect of its interests in China International Capital Corporation Limited;
? China Construction Bank in its acquisition of AIG Finance (Hong Kong) Limited.
